Self-Monitoring Blood Glucose Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The Report Covers Self-Monitoring Blood Glucose Market Revenue, Growth, and Trends. The Market is Segmented by Component (Glucometer Devices, Test Strips, and Lancets) and Geography (North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America). The Market Size and Forecasts are Provided in Terms of Value (in USD) and Volume (in Units) for the Above Segments.

Self-Monitoring Blood Glucose Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

Self-Monitoring Blood Glucose Market Size

Self-monitoring Blood Glucose Market Summary
Study Period 2019 - 2030
Market Size (2025) USD 15.47 Billion
Market Size (2030) USD 20.92 Billion
CAGR (2025 - 2030) 6.23 %
Fastest Growing Market North America
Largest Market North America
Market Concentration High

Major Players

Self-Monitoring Blood Glucose Market Major Players

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of Self-Monitoring Blood Glucose Market with other markets in Healthcare Industry

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

Self-Monitoring Blood Glucose Market Analysis

The Self-Monitoring Blood Glucose Market size is estimated at USD 15.47 billion in 2025, and is expected to reach USD 20.92 billion by 2030, at a CAGR of 6.23% during the forecast period (2025-2030).

During the COVID-19 pandemic, hyperglycemia, caused by both stress and diabetes mellitus, could be present in patients in the intensive care unit or non-ICU patients. The maintenance of euglycemia was essential to decrease both morbidity and mortality. According to experts, inpatient use of diabetes technology in patients with proper institutional protocols was safe and improved inpatient glycemic outcomes and played a vital role in managing hypoglycemia and hyperglycemia in hospitalized patients. According to the article published by the American Association of Clinical Endocrinology in December 2022, the inpatient standard of care for glucose monitoring consisted of capillary glucose measurement using glucometers. COVID-19 treatment involved high doses of corticosteroids with subsequent hyperglycemia and the need for higher insulin doses to control glucose. This dosing required more frequent glucose monitoring with glucometer checks.

According to the International Diabetes Federation (IDF), the adult diabetes population in 2021 is approximately 537 million, and this number is going to increase by 643 million in 2030. The main diagnosis for diabetes patients is imbalances in blood glucose levels, which do not comply with the standard blood glucose levels. General lab diagnostic tests can only help physicians diagnose the disease. Patients with more fluctuations in glucose levels need to get it checked daily. Patients administering insulin need to check their blood glucose levels frequently, adjust their insulin doses, or change the medication if necessary.

Technological advancements in blood glucose meters, including cellular-connected devices that automatically upload SMBG data to secure cloud-based databases, allow for improved sharing and monitoring of SMBG data. Real-time monitoring of SMBG data presents opportunities to provide timely support to patients responding to abnormal SMBG recordings. Such diabetes remote monitoring programs can provide patients with poorly controlled diabetes additional support needed to improve critical outcomes, thereby enhancing the market prospects in the years to come.

Self-Monitoring Blood Glucose Industry Overview

The self-monitoring blood glucose market is consolidated, with a few major manufacturers having a global market presence and occupying a major share, such as Abbott, LifeScan, F. Hoffmann-La Roche AG, and Ascensia, while the remaining confined to the other local or region-specific manufacturers.

Self-Monitoring Blood Glucose Market Leaders

  1. F. Hoffmann-La Roche AG

  2. Abbott Diabetes Care

  3. Ascensia Diabetes Care

  4. LifeScan Inc.

  5. ARKRAY Inc.

  6. *Disclaimer: Major Players sorted in no particular order
Self-monitoring Blood Glucose Market Concentration
Need More Details on Market Players and Competiters?
Download PDF

Self-Monitoring Blood Glucose Market News

  • June 2022: LifeScan announced that the peer-reviewed journal Diabetes Technology and Therapeutics (DTT) published Real World Evidence of Improved Glycemic Control in People with Diabetes using a Bluetooth-connected Blood Glucose Meter with Mobile Diabetes Management Application using the OneTouch Reveal mobile app with the OneTouch Verio Reflect meter which can be synced via the Bluetooth wireless technology. It could support improved glycemic control for people with diabetes.
  • January 2022: Roche launched its new point-of-care blood glucose monitor designed for hospital professionals, with a companion device shaped like a touchscreen smartphone that will run its apps. The hand-held Cobas pulse includes an automated glucose test strip reader, a camera, and a touchscreen for logging other diagnostic results. It’s designed for patients of all ages, including neonates and people in intensive care. The company said Cobas Pulse will start shipping to select European countries, carrying a CE mark, and it plans to seek clearances in the United States and other markets over the year.

Self-Monitoring Blood Glucose Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
  • 4.3 Market Restraints
  • 4.4 Industry Attractiveness - Porter's Five Forces Analysis
    • 4.4.1 Bargaining Power of Suppliers
    • 4.4.2 Bargaining Power of Consumers
    • 4.4.3 Threat of New Entrants
    • 4.4.4 Threat of Substitute Products and Services
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION

  • 5.1 By Component
    • 5.1.1 Glucometer Devices
    • 5.1.2 Test Strips
    • 5.1.3 Lancets
  • 5.2 By End User
    • 5.2.1 Hospital/Clinics
    • 5.2.2 Personal/Home
  • 5.3 By Geography
    • 5.3.1 North America
    • 5.3.1.1 United States
    • 5.3.1.2 Canada
    • 5.3.1.3 Rest of North America
    • 5.3.2 Europe
    • 5.3.2.1 France
    • 5.3.2.2 Germany
    • 5.3.2.3 Italy
    • 5.3.2.4 Spain
    • 5.3.2.5 United Kingdom
    • 5.3.2.6 Russia
    • 5.3.2.7 Rest of Europe
    • 5.3.3 Latin America
    • 5.3.3.1 Mexico
    • 5.3.3.2 Brazil
    • 5.3.3.3 Rest of Latin America
    • 5.3.4 Asia-Pacific
    • 5.3.4.1 Japan
    • 5.3.4.2 South Korea
    • 5.3.4.3 China
    • 5.3.4.4 India
    • 5.3.4.5 Australia
    • 5.3.4.6 Vietnam
    • 5.3.4.7 Malaysia
    • 5.3.4.8 Indonesia
    • 5.3.4.9 Philippines
    • 5.3.4.10 Thailand
    • 5.3.4.11 Rest of Asia-Pacific
    • 5.3.5 Middle East & Africa
    • 5.3.5.1 Saudi Arabia
    • 5.3.5.2 Iran
    • 5.3.5.3 Egypt
    • 5.3.5.4 Oman
    • 5.3.5.5 South Africa
    • 5.3.5.6 Rest of Middle East & Africa

6. MARKET INDICATORS

  • 6.1 Type-1 Diabetes Population
  • 6.2 Type-2 Diabetes Population

7. COMPETITIVE LANDSCAPE

  • 7.1 Company Profiles
    • 7.1.1 Abbott
    • 7.1.2 F. Hoffmann-La Roche AG
    • 7.1.3 LifeScan
    • 7.1.4 Arkray
    • 7.1.5 Ascensia
    • 7.1.6 Agamatrix Inc.
    • 7.1.7 Bionime Corporation
    • 7.1.8 Acon
    • 7.1.9 Medisana
    • 7.1.10 Trivida
    • 7.1.11 Rossmax
  • *List Not Exhaustive
  • 7.2 COMPANY SHARE ANALYSIS
    • 7.2.1 Abbott
    • 7.2.2 Ascensia
    • 7.2.3 F. Hoffmann-La Roche AG
    • 7.2.4 Others

8. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Self-Monitoring Blood Glucose Industry Segmentation

Self-monitoring blood glucose (SMBG) is an important aid in diabetes mellitus care. Patients with diabetes can measure their blood glucose to detect hypoglycemia, adjust the insulin doses as needed, and establish the response to nutrition and pharmacotherapy. 

The Self-monitoring Blood Glucose Market is segmented into Components (Glucometer Devices, Test Strips, and Lancets) and Geography (North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America). The report offers the value (in USD) and volume (in Units) for the above segments.

By Component Glucometer Devices
Test Strips
Lancets
By End User Hospital/Clinics
Personal/Home
By Geography North America United States
Canada
Rest of North America
Europe France
Germany
Italy
Spain
United Kingdom
Russia
Rest of Europe
Latin America Mexico
Brazil
Rest of Latin America
Asia-Pacific Japan
South Korea
China
India
Australia
Vietnam
Malaysia
Indonesia
Philippines
Thailand
Rest of Asia-Pacific
Middle East & Africa Saudi Arabia
Iran
Egypt
Oman
South Africa
Rest of Middle East & Africa
Need A Different Region or Segment?
Customize Now

Self-Monitoring Blood Glucose Market Research FAQs

How big is the Self-Monitoring Blood Glucose Market?

The Self-Monitoring Blood Glucose Market size is expected to reach USD 15.47 billion in 2025 and grow at a CAGR of 6.23% to reach USD 20.92 billion by 2030.

What is the current Self-Monitoring Blood Glucose Market size?

In 2025, the Self-Monitoring Blood Glucose Market size is expected to reach USD 15.47 billion.

Who are the key players in Self-Monitoring Blood Glucose Market?

F. Hoffmann-La Roche AG, Abbott Diabetes Care, Ascensia Diabetes Care, LifeScan Inc. and ARKRAY Inc. are the major companies operating in the Self-Monitoring Blood Glucose Market.

Which is the fastest growing region in Self-Monitoring Blood Glucose Market?

North America is estimated to grow at the highest CAGR over the forecast period (2025-2030).

Which region has the biggest share in Self-Monitoring Blood Glucose Market?

In 2025, the North America accounts for the largest market share in Self-Monitoring Blood Glucose Market.

What years does this Self-Monitoring Blood Glucose Market cover, and what was the market size in 2024?

In 2024, the Self-Monitoring Blood Glucose Market size was estimated at USD 14.51 billion. The report covers the Self-Monitoring Blood Glucose Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Self-Monitoring Blood Glucose Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

Self-Monitoring Blood Glucose Industry Report

Statistics for the 2025 Self-Monitoring Blood Glucose market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Self-Monitoring Blood Glucose analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.